Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.54 |
| ▸ | CPT2 | P23786 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | HMGCR | P04035 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | BHMT | Q93088 | 3/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL371521 | 0.97 | KDM4E (0.52) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL1979018 | 0.97 | KDM4E (0.52) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL17187568 | 0.97 | KDM4E (0.52) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL557257 | 0.88 | KDM4E (0.59) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL12808778 | 0.86 | KDM4E (0.56) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL16675248 | 0.85 | KDM4E (0.46) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL48109 | 0.82 | KDM4E (0.65) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL30854909 | 0.82 | KDM4E (0.65) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL19068470 | 0.80 | KDM4E (0.38) | KDM4EFFAR1CPT2TDP1HMGCR | |
| SCHEMBL11439787 | 0.79 | KDM4E (0.62) | KDM4EFFAR1CPT2TDP1HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399241-A1 | TYRE FOR VEHICLE WHEELS | Pirelli Tyre S.p.A. (IT) | 2024-07-17 | — | — | EP | claimed |
| WO-2023037239-A1 | TYRE FOR VEHICLE WHEELS | PIRELLI TYRE S.P.A. (IT) | 2023-03-16 | — | — | WO | claimed |
| US-12577371-B2 | Oxidatively curable coating composition | MILLIKEN INDUSTRIALS LIMITED (GB) | 2026-03-17 | — | — | US | disclosed |
| US-12570851-B2 | Liquids | MILLIKEN INDUSTRIALS LIMITED (GB) | 2026-03-10 | — | — | US | disclosed |
| EP-3426740-B1 | METHOD OF PREPARING AN OXIDATIVELY CURABLE COATING FORMULATION | MILLIKEN INDUSTRIALS LTD (GB) | 2024-09-11 | — | — | EP | disclosed |
| US-12077652-B2 | Oxidatively curable coating composition | MILLIKEN INDUSTRIALS LIMITED (GB) | 2024-09-03 | — | — | US | disclosed |
| EP-3818115-B1 | OXIDATIVELY CURABLE COATING COMPOSITION | MILLIKEN INDUSTRIALS LTD (GB) | 2023-11-22 | — | — | EP | disclosed |
| US-20230203353-A1 | ADHESIVE FOR ENDOSCOPE AND CURED PRODUCT THEREOF, AND ENDOSCOPE AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230174570-A1 | NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS | HETERO LABS LIMITED (IN) | 2023-06-08 | — | — | US | disclosed |
| EP-3390486-B1 | OXIDATIVELY CURABLE COATING COMPOSITION | MILLIKEN INDUSTRIALS LTD (GB) | 2023-05-03 | — | — | EP | disclosed |
| CN-112313298-B | Oxidatively curable coating compositions | 卡特克塞尔科技有限公司 | 2022-12-02 | — | — | CN | disclosed |
| US-8211932-B2 | Organic compounds and their uses | NOVARTIS AG (CH) | 2012-07-03 | — | — | US | disclosed |
| WO-2012010844-A1 | PRODUCTION PROCESS FOR POLYOL FOR USE IN LOW BALL REBOUND POLYURETHANE FOAMS | NOAKES CHRISTOPHER WICKHAM (CH) | 2012-01-26 | — | — | WO | disclosed |
| US-20110021624-A1 | Alpha-Amino-N-Substituted Amides, Pharmaceutical Composition Containing Them and Uses Thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2011-01-27 | — | — | US | disclosed |
| US-20110015196-A1 | LUPEOL-TYPE TRITERPENE DERIVATIVES AS ANTIVIRALS | HETERO RESEARCH FOUNDATION (IN) | 2011-01-20 | — | — | US | disclosed |
| US-20100331243-A1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2010-12-30 | — | — | US | disclosed |
| US-7825152-B2 | serine protease inhibitors, for the treatment of hepatitis c virus infections | NOVARTIS AG (CH) | 2010-11-02 | — | — | US | disclosed |
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2010-08-12 | — | — | US | disclosed |
| US-20080132506-A1 | Anti-inflammatory medicaments | FLYNN DANIEL L | 2008-06-05 | — | — | US | disclosed |
| US-20070286842-A1 | Organic Compounds and Their Uses | NOVARTIS AG (CH) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331243-A1 | ORGANIC COMPOUNDS AND THEIR USES | OAT, OTC, AOX1 | KDM4E 4021/4885FFAR1 3129/4885CPT2 51/4885 |
| US-12577371-B2 | Oxidatively curable coating composition | TET1, JMJD6, SETDB1 | KDM4E 56/4885FFAR1 687/4885CPT2 736/4885 |
| US-12570851-B2 | Liquids | SOD1, GPX4, SMARCC1 | KDM4E 1517/4885FFAR1 1346/4885CPT2 2225/4885 |
| US-20110015196-A1 | LUPEOL-TYPE TRITERPENE DERIVATIVES AS ANTIVIRALS | MAVS, IRF3, LSS | KDM4E 3378/4885FFAR1 2631/4885CPT2 1551/4885 |
| US-20110021624-A1 | Alpha-Amino-N-Substituted Amides, Pharmaceutical Composition Containing Them and Uses Thereof | AADAT, ASNS, AANAT | KDM4E 1098/4885FFAR1 1780/4885CPT2 3386/4885 |
| US-20070286842-A1 | Organic Compounds and Their Uses | OAT, OTC, AOX1 | KDM4E 4021/4885FFAR1 3129/4885CPT2 51/4885 |
| US-20230174570-A1 | NOVEL TRITERPENE DERIVATIVES AS HIV INHIBITORS | CYP51A1, CCR5, CYP4A11 | KDM4E 1590/4885FFAR1 2978/4885CPT2 3891/4885 |
| US-20100204159-A1 | ORGANIC COMPOUNDS AND THEIR USES | OAT, OTC, AOX1 | KDM4E 4021/4885FFAR1 3129/4885CPT2 51/4885 |
| US-20080132506-A1 | Anti-inflammatory medicaments | MIF, PTGES2, TNF | KDM4E 3081/4885FFAR1 2547/4885CPT2 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.